Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Seres Therapeutics (MCRB) Q4 2023 Earnings
MCRB
5
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.57
-0.2
0.18
0.55
Details
Expected EPS
-0.5
Actual EPS
-0.32
Surprise EPS
0.18
Surprise Percent
+36%
Description
Seres Therapeutics (MCRB) has reported earnings of -0.32 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login